CompaniesByCap
VYNE
Vyne Therapeutics Inc. (VYNE)
NASDAQ · Healthcare

Vyne Therapeutics Inc. Income Statement 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenues
Revenue570,000501,000424,000477,000931,00021.0M443,0003.6M4.6M674,000
Gross Profit
Profitability
Operating Income-29.7M-43.6M-29.3M-34.3M-38.9M-252.5M-95.9M-74.9M-29.6M-14.3M
EBITDA
Net Income-26.5M-39.8M-28.5M-23.2M-73.3M-255.6M-95.2M-74.2M-29.1M-14.1M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)43M43M10M3M3M32M9M23M5M5M

Vyne Therapeutics Inc. Income Statement — FAQ

Vyne Therapeutics Inc. (VYNE) income statement over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VYNE's income statement history?

The chart and table above show Vyne Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.